WHO, the Global Fund, and medical malpractice in malaria treatment
Authors:
- Amir AttaranAAAmir Attaran
- Karen I BarnesKBKaren I Barnes
- Christopher CurtisCCChristopher Curtis
- Umberto D'ALessandroUDUmberto D'ALessandro
- Caterina I FanelloCFCaterina I Fanello
- Mary R GalinskiMGMary R Galinski
- Gilbert KokwaroGKGilbert Kokwaro
- Sornchai LooareesuwanSLSornchai Looareesuwan
- Michael MakangaMMMichael Makanga
- Theonest K MutabingwaTMTheonest K Mutabingwa
- Ambrose TalisunaATAmbrose Talisuna
- Jean François TrapeJTJean François Trape
- 1 January 2004
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 363 (9404) , 237-240
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trialThe Lancet, 2004
- Artesunate combinations for treatment of malaria: meta-analysisThe Lancet, 2004
- Malaria researchers say global fund is buying “useless drug”BMJ, 2003
- About AuthorsOrganization Science, 2003
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in TanzaniaThe Lancet, 2001
- Donor responsibilities in rolling back malariaThe Lancet, 2000
- Averting a malaria disasterThe Lancet, 1999
- Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medicationTrends in Pharmacological Sciences, 1999
- The "Roll Back Malaria" CampaignScience, 1998